Healthcare provider profile · identity verified

Robert W Dodson, M.D.

Internal Medicine · CAPE GIRARDEAU, MO · NPI 1154349231

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	785	190
Omeprazole	Omeprazole	495	117
Lisinopril	Lisinopril	493	136
Levothyroxine Sodium	Levothyroxine Sodium	466	119
Meloxicam	Meloxicam	431	124
Atorvastatin Calcium	Atorvastatin Calcium	422	111
Hydrochlorothiazide	Hydrochlorothiazide	363	102
Pantoprazole Sodium	Pantoprazole Sodium	351	63
Rosuvastatin Calcium	Rosuvastatin Calcium	337	97
Olmesartan Medoxomil	Olmesartan Medoxomil	307	86
Ozempic	Semaglutide	301	43
Losartan Potassium	Losartan Potassium	285	73
Simvastatin	Simvastatin	261	60
Metoprolol Succinate	Metoprolol Succinate	257	72
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	256	30
Gabapentin	Gabapentin	238	72
Jardiance	Empagliflozin	217	40
Metformin Hcl	Metformin Hcl	190	55
Alprazolam	Alprazolam	176	40
Furosemide	Furosemide	173	41
Escitalopram Oxalate	Escitalopram Oxalate	172	44
Tramadol Hcl	Tramadol Hcl	159	42
Duloxetine Hcl	Duloxetine Hcl	152	42
Metformin Hcl Er	Metformin Hcl	152	46
Tamsulosin Hcl	Tamsulosin Hcl	149	44
Fluticasone Propionate	Fluticasone Propionate	146	63
Mounjaro	Tirzepatide	146	27
Trazodone Hcl	Trazodone Hcl	142	41
Sertraline Hcl	Sertraline Hcl	135	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	38
Eliquis	Apixaban	124	26
Atenolol	Atenolol	121	36
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	120	suppressed
Allopurinol	Allopurinol	119	27
Celecoxib	Celecoxib	119	30
Pravastatin Sodium	Pravastatin Sodium	117	29
Metoprolol Tartrate	Metoprolol Tartrate	114	18
Albuterol Sulfate Hfa	Albuterol Sulfate	112	33
Zolpidem Tartrate	Zolpidem Tartrate	109	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	108	27
Xarelto	Rivaroxaban	98	suppressed
Glipizide	Glipizide	91	27
Bupropion Xl	Bupropion Hcl	89	25
Warfarin Sodium	Warfarin Sodium	84	14
Spironolactone	Spironolactone	82	26
Ropinirole Hcl	Ropinirole Hcl	72	15
Carvedilol	Carvedilol	66	25
Lovastatin	Lovastatin	66	17
Montelukast Sodium	Montelukast Sodium	66	23
Clopidogrel	Clopidogrel Bisulfate	62	19
Citalopram Hbr	Citalopram Hydrobromide	61	15
Oxybutynin Chloride	Oxybutynin Chloride	58	suppressed
Propranolol Hcl	Propranolol Hcl	57	suppressed
Famotidine	Famotidine	56	14
Finasteride	Finasteride	56	17
Pregabalin	Pregabalin	53	17
Glipizide Er	Glipizide	51	suppressed
Prednisone	Prednisone	49	40
Chlorthalidone	Chlorthalidone	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	47	18
Potassium Chloride	Potassium Chloride	47	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	14
Synthroid	Levothyroxine Sodium	46	11
Buspirone Hcl	Buspirone Hcl	43	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Mirtazapine	Mirtazapine	39	suppressed
Memantine Hcl	Memantine Hcl	38	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	11
Lorazepam	Lorazepam	37	suppressed
Estradiol	Estradiol	35	12
Telmisartan	Telmisartan	35	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	34	34
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Varenicline Tartrate	Varenicline Tartrate	33	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	11
Irbesartan	Irbesartan	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	13
Myrbetriq	Mirabegron	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Baclofen	Baclofen	29	suppressed
Valsartan	Valsartan	29	11
Clonazepam	Clonazepam	28	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Leflunomide	Leflunomide	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	12
Lansoprazole	Lansoprazole	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Glimepiride	Glimepiride	25	11
Levemir Flexpen	Insulin Detemir	25	suppressed
Doxepin Hcl	Doxepin Hcl	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	18
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	19
Aripiprazole	Aripiprazole	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Topiramate	Topiramate	20	suppressed
Colesevelam Hcl	Colesevelam Hcl	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Azithromycin	Azithromycin	18	17
Novolog	Insulin Aspart	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Temazepam	Temazepam	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error